Multipurpose Prevention Technologies (MPTs) are an innovative class of products that deliver varied combinations of HIV prevention, other STI prevention, and contraception and will improve the lives of women and families worldwide.
This database includes MPT product candidates from 2021 to 2023 that are not in active development. The database outlines detailed product information and can be searched to display products by desired criteria as selected from the drop-down boxes or by entering a keyword in the search box. Click on the product name to access detailed information on each product.
Search MPT Product Development Database
Hormonal / Non-Hormonal
Delivery Route
Delivery Method
Development Stage
Indication
Product Developer
Product Sponsor / Funding
Active Ingredient(s)
Click on the product name for more details.
- Citric Acid
- L-lactic Acid
- Potassium Bitartrate
- Evofem Biosciences, Inc.
- Population Council
- Pre1
- Bacterial Vaginosis (BV)
- Chlamydia
- Gonorrhea
- Pregnancy
- Acyclovir
- Dolutegravir
- Etonogestrel
- Ethinyl Estradiol
- Rilpivirine
- Auritec Pharmaceuticals
- Pre2
- HIV
- HSV-2
- Pregnancy
- Citric Acid
- L-lactic Acid
- Potassium Bitartrate
- Evofem Biosciences, Inc.
- C3
- Pregnancy
- Chlamydia and gonorrhea under clinical investigation
- Griffithsin (GRFT)
- University of Louisville
- Pre1
- Hepatitis
- HIV
- HSV-2
- Monoclonal Antibodies
- Mapp Biopharmaceutical, Inc.
- C1
- HIV
- HSV-2
- Carrageenan
- MIV-150
- Zinc
- Population Council
- C2
- HIV
- HPV
- HSV-2
- Norelgestromin
- ARV candidates under review
- PATH
- Queen's University Belfast
- Pre1
- HIV
- Pregnancy
- QGRFT
- University of Louisville
- University of Pittsburgh
- C1
- Hepatitis
- HIV
- HPV
- HSV-2
- Levonorgestrel
- Tenofovir (TFV)
- CONRAD
- C2
- HIV
- HSV-2
- Pregnancy
Feedback
Know of an MPT product not included in this database or have updated information for listed products? Let us know here!